Literature DB >> 25551797

The effect of bioactive compounds in tea on lipid metabolism and obesity through regulation of peroxisome proliferator-activated receptors.

Sung-Joon Lee1, Yaoyao Jia.   

Abstract

PURPOSE OF REVIEW: The hypolipidemic and antiobesogenic effects of tea intake have been associated with bioactive compounds that regulate peroxisome proliferator-activated receptors (PPARs). This review describes the recent research on two of these compounds, (-)-epigallocatechin gallate (EGCG) and linalool. RECENT
FINDINGS: Catechins (specifically EGCG) are key bioactive compounds found in tea, and a recent study has shown that linalool may also be an active tea compound. These compounds act on lipid metabolism by regulating PPAR subtypes. EGCG inhibits the key adipogenic transcription factor PPARγ while activating PPARα, whereas linalool is a PPARα agonist activating hepatic fatty acid uptake and subsequent oxidation to reduce plasma triglyceride levels.
SUMMARY: The collective activities of EGCG and linalool in tea may exert hypolipidemic and antiobesogenic effects by regulating PPARs. The research summarized in this review expands our understanding of the biological and physiological mechanisms of the bioactive compounds found in tea.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25551797     DOI: 10.1097/MOL.0000000000000145

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  8 in total

1.  Nimbolide attenuate the lipid accumulation, oxidative stress and antioxidant in primary hepatocytes.

Authors:  Ghedeir M Alshammari; Aristatile Balakrishnan; Thirunavukkarasu Chinnasamy
Journal:  Mol Biol Rep       Date:  2017-11-28       Impact factor: 2.316

2.  Green tea extract provides extensive Nrf2-independent protection against lipid accumulation and NFκB pro- inflammatory responses during nonalcoholic steatohepatitis in mice fed a high-fat diet.

Authors:  Jinhui Li; Teryn N Sapper; Eunice Mah; Swetha Rudraiah; Kevin E Schill; Chureeporn Chitchumroonchokchai; Meredith V Moller; Joshua D McDonald; Philip R Rohrer; José E Manautou; Richard S Bruno
Journal:  Mol Nutr Food Res       Date:  2016-02-18       Impact factor: 5.914

3.  Repeated dose studies with pure Epigallocatechin-3-gallate demonstrated dose and route dependant hepatotoxicity with associated dyslipidemia.

Authors:  Balaji Ramachandran; Subramani Jayavelu; Kanchan Murhekar; Thangarajan Rajkumar
Journal:  Toxicol Rep       Date:  2016-03-05

4.  Green tea polyphenol treatment attenuates atherosclerosis in high-fat diet-fed apolipoprotein E-knockout mice via alleviating dyslipidemia and up-regulating autophagy.

Authors:  Shibin Ding; Jinjin Jiang; Pengxin Yu; Guofu Zhang; Guanghui Zhang; Xiaoting Liu
Journal:  PLoS One       Date:  2017-08-04       Impact factor: 3.240

5.  Therapeutic benefits of green tea extract on various parameters in non-alcoholic fatty liver disease patients.

Authors:  Mazhar Hussain; Lubna Akhtar
Journal:  Pak J Med Sci       Date:  2017 Jul-Aug       Impact factor: 1.088

Review 6.  Bioactive Compounds for the Management of Hypertriglyceridemia: Evidence From Clinical Trials and Putative Action Targets.

Authors:  Elisabetta Schiano; Giuseppe Annunziata; Roberto Ciampaglia; Fortuna Iannuzzo; Maria Maisto; Gian Carlo Tenore; Ettore Novellino
Journal:  Front Nutr       Date:  2020-11-30

7.  Z-ligustilide and anti-inflammatory prostaglandins have common biological properties in macrophages and leukocytes.

Authors:  Joseph Schwager; Lidia Gagno; Nathalie Richard; Werner Simon; Peter Weber; Igor Bendik
Journal:  Nutr Metab (Lond)       Date:  2018-01-16       Impact factor: 4.169

Review 8.  PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice.

Authors:  Yaping Wang; Takero Nakajima; Frank J Gonzalez; Naoki Tanaka
Journal:  Int J Mol Sci       Date:  2020-03-17       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.